Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope
- PMID: 8564975
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope
Abstract
Most cervical carcinoma (Cxca) cells constitutively express human papillomavirus type 16 (HPV16) E6 and E7 oncoproteins. These proteins are, therefore, attractive targets for T cell-based immunotherapy. Previously, we identified HVP16 E7-encoded CTL epitopes. In patients with cervical intraepithelial neoplasia or Cxca, little is known concerning T-cell activity against viruses in general and against HPV16 in particular. Here, we have screened the blood of 10 healthy donor controls and of 22 patients with HPV16+ cervical lesions for the presence of CTLs directed against HPV16 E7- and control influenza virus matrix-derived epitopes presented by HLA-A *0201. We detected influenza virus-specific CTLs in all donors and in the majority of patients, indicating that most patients have functioning T-cell responses despite their lesions or therapeutic interventions. Moreover, we show that patients with HPV16+ lesions occasionally have memory CTLs against a HPV16 E7-encoded epitope (sequence YMLD-LQPETT), providing evidence for natural CTL immunity against HPV16 in patients with cervical lesions. Combined, these findings raise possibilities for vaccination with HPV16 E7-encoded peptides to induce or augment CTL responses for treatment or prevention of Cxca.
Similar articles
-
Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.Exp Mol Pathol. 2012 Feb;92(1):185-90. doi: 10.1016/j.yexmp.2011.10.002. Epub 2011 Oct 15. Exp Mol Pathol. 2012. PMID: 22032938
-
In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones.J Immunol. 2003 Sep 15;171(6):2912-21. doi: 10.4049/jimmunol.171.6.2912. J Immunol. 2003. PMID: 12960314
-
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.Vaccine. 2001 Mar 21;19(17-19):2549-56. doi: 10.1016/s0264-410x(00)00488-6. Vaccine. 2001. PMID: 11257391 Review.
-
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.J Immunother. 2000 Mar-Apr;23(2):255-66. doi: 10.1097/00002371-200003000-00010. J Immunother. 2000. PMID: 10746552
-
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.J Immunol. 1995 Jun 1;154(11):5934-43. J Immunol. 1995. PMID: 7538538
Cited by
-
Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.iScience. 2023 Feb 2;26(3):106101. doi: 10.1016/j.isci.2023.106101. eCollection 2023 Mar 17. iScience. 2023. PMID: 36876126 Free PMC article.
-
Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances.Int J Nanomedicine. 2022 Feb 25;17:869-900. doi: 10.2147/IJN.S269986. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35241913 Free PMC article. Review.
-
Immunotherapy for HPV Malignancies.Semin Radiat Oncol. 2021 Oct;31(4):361-370. doi: 10.1016/j.semradonc.2021.02.008. Semin Radiat Oncol. 2021. PMID: 34455991 Free PMC article. Review.
-
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).Clin Cancer Res. 2020 Nov 1;26(21):5621-5630. doi: 10.1158/1078-0432.CCR-20-0776. Epub 2020 Aug 18. Clin Cancer Res. 2020. PMID: 32816895 Free PMC article.
-
The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Prog Mol Biol Transl Sci. 2016;144:169-238. doi: 10.1016/bs.pmbts.2016.09.003. Epub 2016 Oct 11. Prog Mol Biol Transl Sci. 2016. PMID: 27865458 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials